Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of adding Azarga to prostaglandin monotherapy in ocular hypertension or open-angle glaucoma
2010-022948-21Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of brinzolamide in ocular hypertension and open-angle glaucoma (OAG), sponsored by Alcon Inc. Primary endpoint: Change in intraocular pressure at 3 months. Started Dec 2010; status: completed.
02
Drugs
brinzolamide
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2010-022948-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022948-21.